Log in to save to my catalogue

Preclinical evaluation of novel synthesised nanoparticles based on tyrosine poly(ester amide) for im...

Preclinical evaluation of novel synthesised nanoparticles based on tyrosine poly(ester amide) for im...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5650efc3d16e4e6188d24badecda72d0

Preclinical evaluation of novel synthesised nanoparticles based on tyrosine poly(ester amide) for improved targeted pulmonary delivery

About this item

Full title

Preclinical evaluation of novel synthesised nanoparticles based on tyrosine poly(ester amide) for improved targeted pulmonary delivery

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2024-04, Vol.14 (1), p.9845-9845, Article 9845

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Fixed dose combinations (FDCs) incorporating two or three medicines in a single inhaler have been created to enhance patient compliance and hence clinical outcomes. However, the development of dry powder inhalers (DPIs), particularly for FDCs, faces challenges pertinent to formulation uniformity and reproducibility. Therefore, this project aimed to...

Alternative Titles

Full title

Preclinical evaluation of novel synthesised nanoparticles based on tyrosine poly(ester amide) for improved targeted pulmonary delivery

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5650efc3d16e4e6188d24badecda72d0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5650efc3d16e4e6188d24badecda72d0

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-024-59588-1

How to access this item